Nightingale Informatix Corporation Announces Plans to Achieve Class II
Medical Device Licensing by March 1, 2011

MARKHAM, ON, June 24 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) ("Nightingale" or the "Company"), an application service provider (ASP) of electronic medical record (EMR) software and related services today announces that the process to achieving Class II medical device licensing for its Nightingale On Demand EMR system, as mandated by Health Canada, is well underway.

Nightingale is highly supportive of this initiative by Health Canada and is committed to completing the licensing process no later than March 1, 2011, which is well before the Health Canada deadline of September 1, 2011.

"Nightingale On Demand is the core business and clinical system for thousands of medical clinics across Canada," said Sam Chebib, President & CEO of Nightingale. "Quality of systems and services is critical to our customers, and to anyone relying on an EMR as a tool in providing healthcare to their patients. Nightingale is committed to providing the highest quality Patient Management products and services available."

As part of the licensing requirements, Nightingale is in the process of achieving ISO 13485:2003 compliance and certification. ISO 13485:2003 is an international quality standard and is a pre-requisite to achieving Medical Device Class II certification for patient management software companies. MDEL Class II requires software companies to have quality systems and processes in place according to international quality standards. Nightingale's facilities are currently certified under Health Canada Medical Device Class I.

More information about Health Canada Class II Medical Device Licensing and ISO 13485:2003 may be found on Nightingale's website at www.nightingalemd.ca/quality.

About Nightingale Informatix Corporation

Nightingale is one of the fastest growing health care service and software companies in North America. It is recognized as an industry leader in Web-based (ASP) clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected. www.nightingalemd.ca

Forward-Looking Statement

This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully integrate its acquisitions and any liabilities arising as a result of such acquisitions; access to capital and agreements with its Lenders; the existence of present and possible future government regulation; access to debt or equity financing and agreements with its Lenders; the significant and increasing competition that exists in the medical software industry; the early stage of Nightingale's business; and therefore it is subject to the risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Although management believes the assumptions used to make such statements are reasonable at this time, our assumptions may not to be as anticipated, estimated or intended. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding Nightingale's continued ability to fund its business, rates of customer defaults, relationships with, and payments to, lenders, demand for Nightingale's products, as well as Nightingale's operating cost structure.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: Alan Kriss, VP Marketing, Nightingale Informatix Corporation, Tel: [phone], [email protected]